07:35 AM EDT, 06/24/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Monday it has agreed to acquire Alimera Sciences ( ALIM ) in a deal valued at around $381 million.

Under the agreement, ANI will pay $5.50 per share in cash at closing and one non-tradable contingent value right worth up to $0.50 per share upon reaching specific net revenue targets in 2026 and 2027.

The boards of both companies have approved the deal, which is expected to close by late Q3.